Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

ClinicalTrials.gov ID: NCT03179631

Public ClinicalTrials.gov record NCT03179631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension

Study identification

NCT ID
NCT03179631
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
PTC Therapeutics
Industry
Enrollment
360 participants

Conditions and interventions

Eligibility (public fields only)

Age range
5 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2017
Primary completion
Mar 4, 2022
Completion
Jul 24, 2023
Last update posted
Mar 9, 2026

2017 – 2023

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Phoenix Childrens Hospital Phoenix Arizona 85016
Children's Hospital of Los Angeles Los Angeles California 90027
University of California, San Francisco (UCSF) - Benioff Children's Hospital - Oakland Oakland California 94143
Stanford University Medical Center Palo Alto California 94305
University of California (UC) Davis Medical Center Sacramento California 95817
Loma Linda University Children's Hospital San Bernardino California 92408
Northwest Florida Clinical Research Group, LLC Gulf Breeze Florida 32561
Indiana University Health - Riley Child Neurology Indianapolis Indiana 46202
University of Kansas Medical Center Kansas City Kansas 66160
University of Michigan - CS Mott Children's Hospital Ann Arbor Michigan 48109
Children's Hospital of Michigan Detroit Michigan 48201
University of Minnesota Minneapolis Minnesota 55455
Columbia University College of Physicians & Surgeons New York New York 10032
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Shriners Hospital for Children Portland Oregon 97239
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania 15224
Cook Childrens Medical Center Fort Worth Texas 76104
Texas Children's Hospital Houston Texas 77030
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900
University Of Utah Salt Lake City Utah 84112
Children's Hospital of the King's Daughters Norfolk Virginia 23507
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03179631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03179631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →